Brief: Barda And Ortho Collaborate To Advance Development Of High Specificity SARS-CoV-2 Antibody Tests
17/06/2020 14:25
June 17 (Reuters) - Ortho Regenerative Technologies Inc
ORTH.CD :
* BARDA AND ORTHO COLLABORATE TO ADVANCE DEVELOPMENT OF HIGH
SPECIFICITY SARS-COV-2 ANTIBODY TESTS
Source text for Eikon: ID:nCNWPxLHsa
Further company coverage: ORTH.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chitogenx
See all newsBrief: Chitogenx Announces Signing Of Binding Letter Of Intent With Oligo Medic
Brief: Chitogenx Announces Executive Leadership Changes
Brief: Chitogenx Inc - Study Results To Be Available Q3-24 After Mandatory Post-Surgery Monitoring
Brief: Chitogenx Concludes Enrolment For Its U.S. Phase I/II Rotator Cuff Tear Repair Clinical Trial
Brief: Chitogenx Announces New $2.5 Million Non-Brokered Private Placement Offering And Balance Sheet Restructuring